Our coordinated team of clinicians and scientists is dedicated to helping patients with intestinal cancers. We integrate clinical and basic research to translate new discoveries and novel therapeutic strategies into treatments for these patients.  

Our group develops research strategies for primary and metastatic cancers along the gastrointestinal tract. We are especially focused on identifying biomarkers that: 

• Inform patient care
• Are linked with disease prognosis
• Help optimize patient treatment
• Predict and ultimately prevent disease recurrence

We also focus on early detection of recurrent disease. Our collaborative structure enhances the relationships between the surgeon, oncologist, clinician and basic researcher to meet this goal.

Our multidisciplinary group offers members opportunities to share research interests, develop collaborative efforts and ask compelling research questions. The group’s structure improves how we translate basic and clinical research into clinical trials and patient care. Collaborative engagement informs our research projects at their conception. 

Foundations, professional societies and government agencies fund our projects. Our group acts as a platform for larger collaborative research applications and program project grants. We also coordinate with the OHSU Knight Cancer Institute development team to pursue avenues for philanthropic support.